Bestpet Pharmacy

Dosage
Dosage and administration
Galastop® should be administered orally either directly into the mouth or by mixing with food.
The dosage is 0.1 ml/kg bodyweight (equivalent to 5 μg/kg body weight of cabergoline) once daily for 4-6 consecutive days, depending on the severity of the clinical condition.
For dogs less that 5 kg bodyweight it is advisable to measure the dosage in drops, 3 drops being equivalent to 0.1 ml.
If the signs fail to resolve after a single course of treatment, or if they recur after the end of treatment, then the course of treatment may be repeated.
For treatment of false pregnancy, clinical studies have demonstrated efficacy between 80-100%. Behavioural signs are alleviated first, followed by reduction in mammary gland enlargement, then finally suppression of lactation.

For information about the dosage and administration of Galastop Oral Solution please click here Galastop Oral Solution Dosage and Administration

For information about the Contra-indications, warnings, etc of Galastop Oral Solution please click here Galastop Oral Solution Contra-indications, warnings, etc

For further information about Galastop Oral Solution please click here Galastop Oral Solution Further Information

Contra-indications, warnings, etc
Do not use in pregnant animals since Galastop® may cause abortion. Do not use in lactating bitches unless suppression of lactation is required.
Galastop® may induce transient hypotension in treated animals. Do not use in animals concurrently being treated with hypotensive drugs. Do not use directly after surgery whilst the animal is still under the influence of the anaesthetic agents.
Since cabergoline exerts its therapeutic effect by direct stimulation of dopamine receptors, Galastop® should not be administered concurrently with drugs which have dopamine antagonist activity (such as phenothiazines, butyrophenones), as these might reduce its prolactin inhibiting effects.
Vomiting or anorexia may occur after the first one or two doses in a small proportion of cases. There is no need to discontinue treatment unless vomiting is severe or it persists beyond the second dose.
In some animals a degree of drowsiness may be seen in the first 2 days of dosing.
The experimental data indicate that a single overdose with Galastop® might result in an increased likelihood of post-treatment vomiting, and possibly an increase in post-treatment hypotension. General supportive measures should be undertaken to remove any unabsorbed drug and maintain blood pressure, if necessary. It is unlikely that the administration of dopamine antagonist drugs would be necessary, but this course of action could be considered.
For animal treatment only. Keep out of reach and sight of children.

Pharmaceutical precautions
Store below 25°C. Protect from light. Do not refrigerate. After opening, use the product within 28 days.

Legal category;-

POM-V

Further information
Nil.

Prescription Items

Non Prescription Items